WY-14643, a Potent Peroxisome Proliferator Activator Receptor-α PPAR-α Agonist Ameliorates the Inflammatory Process Associated to Experimental Periodontitis.
We have investigated the effects of WY14643, a potent peroxisome proliferator activator receptor-α (PPAR-α) agonist, in a rat model of ligature-induced periodontitis. Male Sprague-Dawley rats were lightly anaesthetized with pentobarbitone (35 mg/kg). Sterile, 2-0 black braided silk thread was placed around the cervix of the lower left first molar and knotted medially. Animals received WY14643 (1 mg/kg i.p, daily for eight days). Eighths days after placement of the ligature, we evaluated several markers of inflammation such us (1) myeloperoxidase activity, (2) a cytokines and adhesion molecules expression, (3) NF-κB expression, (4) iNOS expression, (5) the nitration of tyrosine residues, (6) activation of the nuclear enzyme poly(ADP-ribose) polymerase, (7) apoptosis, and (8) the degree of gingivomucosal tissues injury. Administration of WY14643 significantly decreased all of the parameters of inflammation as described above. These results demonstrate that WY14643 exerts an anti-inflammatory role during experimental periodontitis and is able to ameliorate the tissue damage.
Istituto Policattedra di Odontostomatologia, Universita degli Studi di Messina, 98100 Messina, Italy.
Enrico
E
Briguglio
Rosanna
R
Di Paola
Irene
I
Paterniti
Emanuela
E
Mazzon
Giacomo
G
Oteri
Giancarlo
G
Cordasco
Salvatore
S
Cuzzocrea
Nitric Oxide. 2006 Aug;15(1):77-86
16621629
J Immunol. 2004 May 1;172(9):5790-8
15100326
Clin Mol Pathol. 1996 Oct;49(5):M247-55
16696085
J Immunol. 2008 Jan 1;180(1):609-17
18097063
J Periodontol. 1994 May;65(5 Suppl):521-9
8046568
J Periodontal Res. 2000 Dec;35(6):369-73
11144410
J Rheumatol. 1998 Sep;25(9):1785-93
9733461
Community Dent Oral Epidemiol. 2004 Aug;32(4):239-49
15239775
J Dent Res. 2006 Feb;85(2):156-61
16434734
Gastroenterology. 1995 Nov;109(5):1475-83
7557128
J Dent Res. 2007 Sep;86(9):873-7
17720858
Periodontol 2000. 2000 Oct;24:239-52
11276870
Ital Heart J. 2004 Nov;5(11):857-63
15633442
J Clin Periodontol. 2007 Feb;34(2):95-102
17309584
J Bacteriol. 2001 Jun;183(12):3770-83
11371542
Shock. 2004 Oct;22(4):340-6
15377889
J Biol Chem. 2000 Nov 24;275(47):36703-7
10980195
Science. 1988 May 13;240(4854):889-95
3283939
J Biol Chem. 2001 Sep 7;276(36):33471-7
11418615
Lab Invest. 2004 Dec;84(12):1643-54
15492755
J Am Soc Nephrol. 2002 Sep;13(9):2223-31
12191966
Biochem J. 2001 Feb 15;354(Pt 1):225-32
11171098
J Pharmacol Methods. 1985 Nov;14(3):157-67
2997548
Oral Dis. 2000 May;6(3):138-51
10822357
Infect Immun. 1994 Dec;62(12):5205-12
7525481
J Biol Chem. 1999 Nov 5;274(45):32048-54
10542237
J Immunol. 2007 Nov 15;179(10):7021-9
17982093
Head Face Med. 2006 Jun 20;2:17
16787530
J Clin Periodontol. 1996 Jan;23(1):38-44
8636455
J Periodontol. 1996 May;67(5):515-22
8724710
Periodontol 2000. 1994 Jun;5:66-77
9673163
J Dent Res. 2004 Apr;83(4):343-8
15044511
J Endocrinol. 2001 Jun;169(3):453-9
11375115